C, explains why a prostate cancer diagnosis should be seen as a change in direction, not an ending, and how patients can lean ...

Dr. Morana Vojnic answers common questions about brain cancer, including diagnosis, tumor types, treatment effects, ...

Longer follow-up presented at the 2026 ESMO Congress showed that four already-approved treatments for early breast cancer, ...

CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and ...

Four phase 3 trials at ESMO 2026 brought news for people with small cell, EGFR, MET and KRAS G12C lung cancer, plus a caution ...

Five phase 3 trials presented at ESMO 2026 showed new options in small cell lung, bladder, prostate, KRAS G12C lung and ...

C, discusses why he built the MyUrova app and how men with prostate, bladder, kidney or testicular cancer can prepare for ...

A clinical trial will test zanubrutinib plus sonrotoclax as a fixed-duration, chemotherapy-free treatment for hairy cell ...

For people with lung or pancreatic cancer driven by changes in the KRAS gene, research presented at the 2026 European Society ...

Two phase 3 trials at ESMO 2026 brought new options for advanced endometrial cancer, and final results for Verzenio after another CDK4/6 drug showed a survival difference that was not statistically ...

Testicular cancer survivor Brian Sluga shares how faith, journaling and new goals, like training for marathons, helped him ...

Kreitman of the National Cancer Institute has spent more than three decades working on hairy cell leukemia (HCL). He first ...